AKRO – akero therapeutics, inc. (US:NASDAQ)

DELAYED


Volume Shares
1 Day Range
Volume Ratio
52 Week High
52 Week Low


VWAP
Today’s Volatility
20 Day Volatility
Open
Prior Close

YTD

1 Day

AKRO

SPY

QQQ

Swipe to see more

Main News & Impact Reports

Date

Time

Symbol

Headline

Impact

12/18

09:09 pm

akro

Form 4 Akero Therapeutics, Inc. For: Dec 16 Filed by: Young Jonathan

Low Report

Form 4 Akero Therapeutics, Inc. For: Dec 16 Filed by: Young Jonathan

Report

12/18

09:04 pm

akro

Form 4 Akero Therapeutics, Inc. For: Dec 16 Filed by: Lamy Patrick

Low Report

Form 4 Akero Therapeutics, Inc. For: Dec 16 Filed by: Lamy Patrick

Report

12/18

09:02 pm

akro

Form 4 Akero Therapeutics, Inc. For: Dec 16 Filed by: Yale Catriona

Low Report

Form 4 Akero Therapeutics, Inc. For: Dec 16 Filed by: Yale Catriona

Report

12/18

08:59 pm

akro

Form 4 Akero Therapeutics, Inc. For: Dec 16 Filed by: White William Richard

Low Report

Form 4 Akero Therapeutics, Inc. For: Dec 16 Filed by: White William Richard

Report

12/18

08:57 pm

akro

Form 4 Akero Therapeutics, Inc. For: Dec 16 Filed by: Gangloff Scott A.

Low Report

Form 4 Akero Therapeutics, Inc. For: Dec 16 Filed by: Gangloff Scott A.

Report

12/18

08:53 pm

akro

Form 4 Akero Therapeutics, Inc. For: Dec 16 Filed by: Rolph Timothy

Low Report

Form 4 Akero Therapeutics, Inc. For: Dec 16 Filed by: Rolph Timothy

Report

12/18

08:51 pm

akro

Form 4 Akero Therapeutics, Inc. For: Dec 16 Filed by: Cheng Andrew

Low Report

Form 4 Akero Therapeutics, Inc. For: Dec 16 Filed by: Cheng Andrew

Report

12/16

04:30 pm

akro

Form 144 Akero Therapeutics, Inc. Filed by: Lamy Patrick

Medium Report

Form 144 Akero Therapeutics, Inc. Filed by: Lamy Patrick

Report

12/12

08:44 pm

akro

Form 4 Akero Therapeutics, Inc. For: Dec 10 Filed by: Rolph Timothy

Low Report

Form 4 Akero Therapeutics, Inc. For: Dec 10 Filed by: Rolph Timothy

Report

12/12

08:39 pm

akro

Form 4 Akero Therapeutics, Inc. For: Dec 10 Filed by: Young Jonathan

Low Report

Form 4 Akero Therapeutics, Inc. For: Dec 10 Filed by: Young Jonathan

Report

12/12

08:30 pm

akro

Form 4 Akero Therapeutics, Inc. For: Dec 10 Filed by: Lamy Patrick

Low Report

Form 4 Akero Therapeutics, Inc. For: Dec 10 Filed by: Lamy Patrick

Report

12/12

08:28 pm

akro

Form 4 Akero Therapeutics, Inc. For: Dec 10 Filed by: Yale Catriona

Low Report

Form 4 Akero Therapeutics, Inc. For: Dec 10 Filed by: Yale Catriona

Report

12/12

08:27 pm

akro

Form 4 Akero Therapeutics, Inc. For: Dec 10 Filed by: White William Richard

Low Report

Form 4 Akero Therapeutics, Inc. For: Dec 10 Filed by: White William Richard

Report

12/12

08:25 pm

akro

Form 4 Akero Therapeutics, Inc. For: Dec 10 Filed by: Cheng Andrew

Low Report

Form 4 Akero Therapeutics, Inc. For: Dec 10 Filed by: Cheng Andrew

Report

12/10

04:26 pm

akro

Form 144 Akero Therapeutics, Inc. Filed by: Rolph Timothy

Low Report

Form 144 Akero Therapeutics, Inc. Filed by: Rolph Timothy

Report

12/4

07:37 pm

akro

Form 4 Akero Therapeutics, Inc. For: Dec 02 Filed by: Cheng Andrew

Medium Report

Form 4 Akero Therapeutics, Inc. For: Dec 02 Filed by: Cheng Andrew

Report

12/4

07:35 pm

akro

Form 4 Akero Therapeutics, Inc. For: Dec 02 Filed by: Young Jonathan

Medium Report

Form 4 Akero Therapeutics, Inc. For: Dec 02 Filed by: Young Jonathan

Report

11/19

09:58 pm

akro

Form 4 Akero Therapeutics, Inc. For: Nov 15 Filed by: Yale Catriona

Low Report

Form 4 Akero Therapeutics, Inc. For: Nov 15 Filed by: Yale Catriona

Report

11/14

04:00 pm

akro

Form SC 13G/A Akero Therapeutics, Inc. Filed by: JANUS HENDERSON GROUP PLC

Medium Report

Form SC 13G/A Akero Therapeutics, Inc. Filed by: JANUS HENDERSON GROUP PLC

Report

11/14

01:24 pm

akro

Form SC 13G/A Akero Therapeutics, Inc. Filed by: PRICE T ROWE ASSOCIATES INC /MD/

Low Report

Form SC 13G/A Akero Therapeutics, Inc. Filed by: PRICE T ROWE ASSOCIATES INC /MD/

Report

11/14

06:52 am

akro

Form SC 13G/A Akero Therapeutics, Inc. Filed by: RTW INVESTMENTS, LP

Medium Report

Form SC 13G/A Akero Therapeutics, Inc. Filed by: RTW INVESTMENTS, LP

Report

11/13

09:46 am

akro

Form SC 13G/A Akero Therapeutics, Inc. Filed by: ALKEON CAPITAL MANAGEMENT LLC

Medium Report

Form SC 13G/A Akero Therapeutics, Inc. Filed by: ALKEON CAPITAL MANAGEMENT LLC

Report

11/8

05:06 pm

akro

Form 4 Akero Therapeutics, Inc. For: Nov 06 Filed by: Yale Catriona

Low Report

Form 4 Akero Therapeutics, Inc. For: Nov 06 Filed by: Yale Catriona

Report

11/8

10:53 am

akro

Form SC 13G/A Akero Therapeutics, Inc. Filed by: WELLINGTON MANAGEMENT GROUP LLP

Low Report

Form SC 13G/A Akero Therapeutics, Inc. Filed by: WELLINGTON MANAGEMENT GROUP LLP

Report

11/8

07:31 am

akro

Form 10-Q Akero Therapeutics, Inc. For: Sep 30

Medium Report

Form 10-Q Akero Therapeutics, Inc. For: Sep 30

Report

In short, News Quantified specializes in matching financial news with market data. We've analyzed 10s of millions of news events and know exactly which ones have an outsized impact on stock prices. So every single time a news item is released we know exactly what the average effect will be on a particular stock.